Pitfalls in assessing renal function in patients with cirrhosis-potential inequity for access to treatment of hepatorenal failure and liver transplantation

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2735-2742

  Davenport, Andrew ^a   Cholongitas, Evangelos ^a   Xirouchakis, Elias ^a   Burroughs, Andrew Kenneth ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

chronic liver disease; cirrhosis; cystatin C; GFR; renal function creatinine

Indexed keywords

ASCORBIC ACID; BILIRUBIN; CALCITRIOL; CEPHALOSPORIN DERIVATIVE; CREATININE; CYSTATIN; DIURETIC AGENT; DOPAMINE; IODINATED CONTRAST MEDIUM; PHENINDIONE;

ACCURACY; ACUTE KIDNEY FAILURE; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYSTATIN C BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; ISOTOPE DILUTION ASSAY; KIDNEY FUNCTION TEST; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MATHEMATICAL MODEL; MELD SCORE; MUSCLE MASS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SIDE EFFECT; STANDARDIZATION;

ACUTE KIDNEY INJURY; FIBROSIS; GLOMERULAR FILTRATION RATE; HEPATORENAL SYNDROME; HUMANS; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION;

EID: 80053203775     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr354     Document Type: Article

References (78)

1. Cholongitas E, Senzolo M, Patch D et al. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol 2009; 21: 744-750
2. Jenq CC, Tsai MH, Tian YC et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007; 33: 1921-1930
3. Gonwa TA, McBride MA, Anderson K et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead Us? Am J Transplant 2006; 6: 2651-2659 (Pubitemid 44571685)
4. KDIGO Clinical Practice Guidelines. Improving Global Outcomes Clinical Practice Guidelines on Acute Kidney Injury. www.kdigo. org/clinical-practice- guidelines-3.php
5. Salerno F, Gerbes A, Ginès P et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-1318 (Pubitemid 47300435)
6. Sanyal AJ, Boyer T, Garcia-Tsao G et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008; 134: 1360-1368 (Pubitemid 351615358)
7. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 (Pubitemid 32119037)
8. Cholongitas E, Marelli L, Kerry A et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias. Am J Transplant 2007; 7: 685-692 (Pubitemid 46376449)
9. Sharma P, Schaubel DE, Sim CS et al. Re-weighting the model for end-stage liver disease score components. Gastroenterology 2008; 135: 1575-1581
10. Huo S, Terault NA, Vittinghoff E et al. Is the corrected creatinine model for end stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation 2007; 84: 1406-1412 (Pubitemid 350294715)
11. Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol 2010; 7: 659-668
12. Krag A, Møller S, Henriksen JH et al. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 2007; 46: 1863-1871
13. Triantos CK, Samonakis D, Thalmeimer U et al. Terlipressin therapy for renal failure in cirrhotics. Eur J Gastroenterol Hepatol 2010; 22: 481-486
14. Cocchetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit 1983; 5: 161-167
15. Seronie-Vivien S, Galteau MM, Carlier MC et al. Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum. Clin Chem Lab Med 2005; 43: 1227-1233 (Pubitemid 41600676)
16. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med 1988; 39: 465-490 (Pubitemid 19090815)
17. Jafar TH, Schmid CH, Levey AS. Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. J Am Soc Nephrol 2005; 16: 1413-1419 (Pubitemid 41716525)
18. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-1953
19. Proulx NL, Akbari A, Garg AX et al. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant 2005; 20: 1617-1622 (Pubitemid 41418585)
20. Peake M, Whiting M. Measurement of serum creatinine-current status and future goals. Clin Biochem Rev 2006; 27: 173-184
21. Goulding C, Cholongitas E, Nair D et al. Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. Nephrol Dial Transplant 2010; 25: 960-966
22. Delanghe JR, Cobbaert C, Galteau MM et al. Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group. Clin Chem Lab Med 2008; 46: 1319-1325
23. Delanghe JR, Cobbaert C, Harmoinen A et al. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization. Clin Chem Lab Med 2011, doi: 10.1515/CCLM.2011.167
24. Papatheodoridis GV, Cholongitas E, Dimitriadou E et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005; 11: 3099-3104 (Pubitemid 40790670)
25. Lim YS, Larson TS, Benson JT et al. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol 2010; 52: 523-528
26. Moylan CA, Brady CW, Johnson JL et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 2371-2378
27. Axelrod DA, Pomfret EA. Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA 2008; 300: 2425-2426
28. Cholongitas E, Marelli L, Kerry A et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2006; 13: 523-529 (Pubitemid 46605854)
29. Lisman T, van Leeuwen Y, Adelmeijer J et al. Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int 2008; 28: 1344-1351
30. Jacobson HR. Altered permeability in the proximal tubule response to cyclic AMP. Am J Physiol 1979; 236: F71-F79 (Pubitemid 9137152)
31. Caregaro L, Menon F, Angeli P et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154: 201-205 (Pubitemid 24032194)
32. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
33. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 (Pubitemid 29135798)
34. Gonwa TA, Jennings L, Mai ML et al. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-309 (Pubitemid 38240131)
35. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18 (Pubitemid 43032461)
36. White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the Aus-Diab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660-670
37. Rognant N, Bacchetta J, Dubourg L et al. What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transplant 2010; 25: 3569-3575
38. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
39. Hetu PO, Gingras ME, Vinet B. Development and validation of a rapid liquid chromatography isotope dilution tandem mass spectrometry (LC-IDMS/MS) method for serum creatinine. Clin Biochem 2010; 43: 1158-1162
40. Orlando R, Mussap M, Plebani M et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 850-858 (Pubitemid 34587584)
41. Demirtas S, Bozbas A, Akbay A et al. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 81-89 (Pubitemid 32889693)
42. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031 (Pubitemid 37220307)
43. Larsson A, Malm J, Grubb A et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30 (Pubitemid 38283206)
44. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003; 18: 981-985 (Pubitemid 37236209)
45. Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol 2007; 27: 197-205 (Pubitemid 46588187)
46. Keevil BG, Kilpatrick ES, Nichols SP et al. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-1539 (Pubitemid 28309116)
47. Larsson A, Akerstedt T, Hansson LO et al. Circadian variability of cystatin C, creatinine, and glomerular filtration rate (GFR) in healthy men during normal sleep and after an acute shift of sleep. Chronobiol Int 2008; 25: 1047-1061
48. Evangelopoulos AA, Vallianou NG, Bountziouka V et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J 2011. doi: 10.1111/j.1445-5994.2011.02500
49. Odden MC, Tager IB, Gansevoort RT et al. Age and cystatin C in healthy adults: a collaborative study. Nephrol Dial Transplant 2010; 25: 463-469
50. Shlipak MG, Weekley CC, Li Y et al. Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the heart and soul study. Clin Chem 2011; 57: 737-745
51. Singh D, Whooley MA, Ix JH et al. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 2007; 22: 1087-1092 (Pubitemid 46523422)
52. Filler G, Bokenkamp A, Hofmann W et al. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005; 38: 1-8 (Pubitemid 39647648)
53. Larsson A, Hansson LO, Flodin M et al. Calibration of the Siemens Cystatin C Immunoassay Has Changed over time. Clin Chem 2011; 57: 777-778
54. Grubb A, Blirup-Jensen S, Lindström V et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010; 48: 1619-1621
55. Ustundag Y, Samsar U, Acikgoz S et al. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med 2007; 45: 890-894 (Pubitemid 47041878)
56. Pöge U, Gerhardt T, Stoffel-Wagner B et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21: 660-664 (Pubitemid 43372911)
57. Xirouchakis E, Marelli L, Cholongitas E et al. Comparison of cystatin C and creatinine based glomerular filtration rate formulae with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol 2011; 6: 84-92
58. Kuan Y, Hossain M, Surman J et al. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005; 20: 2394-2401 (Pubitemid 41548862)
59. Stevens LA, Coresh J, Greene T et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483 (Pubitemid 43855050)
60. Gaspari F, Perico N, Ruggenenti P et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995; 6: 257-263
61. Kwong YT, Stevens LA, Selvin E et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis 2010; 56: 39-49
62. Michels WM, Grootendorst DC, Rozemeijer K et al. Glomerular filtration rate measurements by 125I-iothalamate should be corrected for inaccurate urine collections with 131I-hippuran. Clin Nephrol 2009; 72: 337-343
63. Boudreau RJ, Carpenter RT, Hasselquist BE et al. A comparison of single blood sample and multiple blood sample methods to measure GFR in a pediatric population. Clin Nucl Med 1994; 19: 493-498 (Pubitemid 24180750)
64. Brändström E, Grzegorczyk A, Jacobsson L et al. GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-1182 (Pubitemid 28227194)
65. Henriksen JH, Brøchner-Mortensen J, Malchow-Møller A et al. Overestimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites. Scand J Clin Lab Invest 1980; 40: 279-284 (Pubitemid 10060524)
66. Sterner G, Frennby B, Mansson S et al. Determining 'true' glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand J Urol Nephrol 2008; 42: 278-285 (Pubitemid 351574390)
67. Fürstenberg A, Davenport A. Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy X-ray absorptiometry. Am J Nephrol 2011; 33: 150-156
68. Fürstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis 2011; 57: 123-129
69. Björk J, Bäck SE, Sterner G et al. Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest 2007; 67: 678-695 (Pubitemid 350034643)
70. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871
71. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098
72. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Pediatr 1978; 93: 62-66 (Pubitemid 8351870)
73. Fujimoto S, Watanabe T, Sakamoto A et al. Studies on the physical surface area of Japanese. 18. Calculation formulae in three stages over all ages. Nippon Eiseigaku Zasshi 1968; 23: 443-450
74. Wong F, Nadim MK, Kellum JA et al. A working party's proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60: 702-709
75. Davenport A. Difficulties in assessing renal function in patients with cirrhosis-potential impact on patient treatment. Intensive Care Med 2011; 37: 930-932
76. Cholangitis E, Shusang V, Marelli L et al. Review article: renal function assessment in cirrhosis-difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969-978 (Pubitemid 47421959)
77. Rule AD, Bailey KR, Schwartz GL et al. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75: 1071-1078
78. Lai J, Terault NA, Vittinghoff E et al. Height explains the gender difference in wait-list mortality under the MELD based liver allocation system. Am J Transplant 2010; 10: 2658-2664